Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
GlucoBreak is a multi-ingredient dietary supplement formulated to support healthy blood glucose levels and metabolic function. It typically contains a blend of botanical extracts, vitamins, and minerals, such as chromium picolinate, cinnamon bark extract, alpha-lipoic acid, and gymnema sylvestre. These components are intended to enhance insulin sensitivity, modulate carbohydrate absorption in the digestive tract, and provide antioxidant support to mitigate oxidative stress associated with glycemic fluctuations. While marketed as a nutritional aid for blood sugar management, it is classified as a nutraceutical and is not an FDA-approved pharmaceutical for the treatment of diabetes mellitus or other medical conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on GlucoBreak.